Naive CD4 + T cells differentiate into diverse effector and regulatory lineages to orchestrate immunity and tolerance. Here we found that the differentiation of proinflammatory T helper type 1 (T H 1) cells and anti-inflammatory Foxp3 + regulatory T cells (T reg cells) was reciprocally regulated by S1P 1 , a receptor for the bioactive lipid sphingosine 1-phosphate (S1P). S1P 1 inhibited the generation of extrathymic and natural T reg cells while driving T H 1 development in a reciprocal manner and disrupted immune homeostasis. S1P 1 signaled through the kinase mTOR and antagonized the function of transforming growth factor-b mainly by attenuating sustained activity of the signal transducer Smad3. S1P 1 function was dependent on endogenous sphingosine kinase activity. Notably, two seemingly unrelated immunosuppressants, FTY720 and rapamycin, targeted the same S1P 1 and mTOR pathway to regulate the dichotomy between T H 1 cells and T reg cells. Our studies establish an S1P 1 -mTOR axis that controls T cell lineage specification.
CD4 + helper T cells are central regulators of adaptive immune responses. In response to antigen stimulation, naive CD4 + T cells proliferate and differentiate into T helper type 1 (T H 1) cells, T H 2 cells and interleukin 17 (IL-17)-producing helper T cells (T H 17) cells to exert specific effector functions. These effector T cells are characterized by distinct patterns of cytokine secretion; interferon-γ (IFN-γ), IL-4 and IL-17 are the signature cytokines for T H 1, T H 2 and T H 17 cells, respectively 1 . Naive precursor cells can also develop into antigen-specific Foxp3 + T reg cells, known as 'induced T reg cells' (iT reg cells), which act in synergy with naturally occurring T reg cells (nT reg cells) to establish immune tolerance and counterbalance effector T cell functions 2, 3 . Induction of iT reg cells in the peripheral immune compartment is closely related to the generation of T H 17 cells, as the differentiation of both lineages is dependent on the pleiotropic cytokine transforming growth factor-β (TGF-β (A002271)) 4 . Despite extensive progress in this area, how the differentiation of naive precursor cells into opposing regulatory and effector lineages is regulated remains poorly understood.
T cell differentiation is programmed by polarizing cytokines, which signal through cell surface cytokine receptors and intracellular pathways, ultimately leading to the expression of lineage-specific transcription factors and effector cytokines. IL-12, IL-4 and TGF-β drive the differentiation of T H 1, T H 2 and iT reg cells, respectively, whereas stimulation by TGF-β together with IL-6 or IL-21 promotes the development of T H 17 cells 1 . The differentiation of T cells is further shaped by non-cytokine receptors, especially those of the nuclear receptor superfamily that recognize endogenous metabolites, environmental toxins and other immune modulators. Retinoic acid, a vitamin A metabolite, directs reciprocal T H 17 and iT reg differentiation by activating the retinoic acid receptor [5] [6] [7] . Aryl hydrocarbon receptor, a transcription factor activated by environmental toxins, regulates T reg and T H 17 differentiation in a ligand-specific way 8, 9 . Aside from the cytokine and nuclear receptors, whether other classes of receptors directly control T cell lineage choices has not been well established.
Sphingosine 1-phosphate (S1P) is a bioactive lysophospholipid that signals through five known G protein-coupled receptors (S1P 1 -S1P 5 ) 10 . FTY720, a new immunosuppressant, induces the sequestration of T cells in lymphoid organs by acting on four of the five S1P receptors. FTY720 is effective in relapsing multiple sclerosis and has become the first oral therapy for this debilitating autoimmune disease 11 . However, the mechanism of action for FTY270 is complex, and it remains controversial whether FTY720 acts as an agonist or a functional antagonist or both to regulate lymphocyte trafficking. Genetic approaches to alter the function of S1P 1 (A000813) have indicated that S1P 1 is the main S1P receptor that facilitates the egress of T cells from lymphoid organs 12, 13 . Experiments with gain-and loss-of-function genetic systems have shown a previously unknown role for S1P 1 in the negative control of the thymic generation and suppressive activity of nT reg cells in a process dependent on the downstream pathway of the kinases Akt and mTOR (A000094) 14 .
To investigate the function of S1P 1 in the lineage determination of peripheral T cells, we used a combination of genetic systems and pharmacological approaches. We found that S1P 1 inhibited the differentiation of Foxp3 + T reg cells while promoting the development of T H 1 cells in a reciprocal manner. S1P 1 antagonized TGF-β receptor function, through an inhibitory effect on Smad3 activity, to control the dichotomy between these two T cell lineages. Moreover, this regulatory function was dependent on the ability of S1P 1 to sustain mTOR activation in T cells. Our studies demonstrate that the differentiation of proinflammatory T H 1 cells and anti-inflammatory T reg cells is reciprocally regulated by S1P 1 -mTOR and the opposing TGF-β-Smad3 signaling. 1 0 4 8 VOLUME 11 NUMBER 11 NOVEMBER 2010 nature immunology A r t i c l e s RESULTS S1P 1 
blocks iT reg differentiation
To gain insight into the mechanisms of iT reg differentiation, we determined the role of S1P 1 in this process. First, we crossed mice expressing a T cell-specific transgene encoding S1P 1 (S1pr1; called 'S1P 1 -Tg mice' here), which expressed two-to threefold more S1P 1 than did wild-type mice (data not shown) 13 , with OT-II transgenic mice (which express CD4 + T cell antigen receptors (TCRs) specific for ovalbumin (OVA)) on a recombination activating-gene 1-deficient (Rag1 −/− ) background. Placing a TCR transgene on the Rag1 −/− background results in all peripheral T cells' having single antigen specificity without detectable expression of the transcription factor Foxp3, which eliminates the confounding effects of S1P 1 function in the nT reg cell compartment 14 . In a model of oral antigen-induced generation of iT reg cells 6,7 , Foxp3 induction was much lower in the mesenteric lymph nodes (MLNs) and spleens of S1P 1 -Tg OT-II Rag1 −/− mice than in the control OT-II Rag1 −/− mice ( Fig. 1a) . Expression of the T reg cell-specific factors LAG-3 and Gpr83 was also lower in S1P 1 -Tg OT-II Rag1 −/− T cells ( Fig. 1b) . We observed more pronounced effects in the lamina propria, in which an extensive Foxp3 + population was induced in OVA-fed OT-II Rag1 −/− mice but not in S1P 1 -Tg OT-II Rag1 −/− mice, despite the similar numbers and distribution of total CD3 + cells in these mice ( Fig. 1c) . To formally exclude the possibility of a contribution of the residual thymus-derived nT reg cells, we crossed S1P 1 -Tg OT-II mice with mice in which a gene encoding green fluorescent protein (GFP) is knocked into the Foxp3 allele (Foxp3 gfp knock-in mice), which marks Foxp3 expression with GFP to distinguish T reg cells and conventional T cells 14 . We purified naive Foxp3 − T cells from the progeny ofthese mice and transferred them into wild-type immunocompetent mice. The administration of oral antigen to the recipients induced a sizable Foxp3 + population from wild-type donors, whereas the Foxp3 + population from S1P 1 -Tg donors was 70% smaller (Supplementary Fig. 1 ). Thus, S1P 1 inhibits new induction of Foxp3-expressing iT reg cells from the peripheral T cell pool.
A specialized subset of dendritic cells (DCs) in the mucosa that expresses CD103 is tolerogenic by inducing Foxp3 + iT reg cells 6, 7 . We purified CD103 + DCs from MLNs and cultured them with naive T cells from OT-II Foxp3 gfp mice (CD62L hi CD44 lo Foxp3 − T cells) in the presence of the cognate antigen or antibody to CD3 (anti-CD3). Under these conditions, a substantial population of T cells from OT-II Foxp3 gfp mice was induced to express Foxp3, whereas S1P 1 -Tg OT-II Foxp3 gfp T cells showed profound defects in Foxp3 induction ( Fig. 1d) . One key mechanism for CD103 + DC-mediated T reg cell differentiation involves the production of TGF-β 6, 7 . Indeed, neutralizing TGF-β abrogated the ability of these DCs to induce Foxp3 expression from wild-type and S1P 1 -Tg cells (data not shown). We conclude that S1P 1 inhibits DC-induced iT reg generation.
Foxp3 + cells can be generated directly from naive precursor cells by antigen stimulation in the presence of TGF-β 15 . When naive cells were activated in the presence of TGF-β in antigen-presenting cellfree conditions, those expressing the S1P 1 transgene were considerably impaired in their ablity to differentiate into Foxp3 + iT reg cells ( Fig. 1e) . Wild-type and S1P 1 -Tg cells proliferated to a similar degree and had similar expression of apoptotic markers and the antiapoptosis molecule Bcl-2 ( Fig. 1e and data not shown). Furthermore, crossing S1P 1 -Tg mice with mice expressing a transgene encoding Bcl-2 failed to rectify the diminished iT reg differentiation (data not shown). Thus, the impaired generation of iT reg cells was not due to altered T cell proliferation or survival, which indicated that S1P 1 inhibits TGF-βmediated iT reg differentiation.
We next explored the kinetics involved in S1P 1 -dependent inhibition of Foxp3 induction. In wild-type cells, Foxp3 mRNA was considerably induced at 24 h after TGF-β stimulation and continued
Foxp3
15.9 S1P 1 -Tg WT S1P 1 -Tg to increase at 36-48 h. S1P 1 -Tg cells had much lower Foxp3 expression at 24-48 h (Fig. 1f ). In addition, transduction of wild-type cells with retrovirus expressing S1P 1 , followed by TGF-β treatment, resulted in less Foxp3 induction. Moreover, S1P 1 exerted its inhibitory effect on Foxp3 induction even when transduction occurred 20-24 h after TGF-β stimulation ( Supplementary Fig. 2 ), which suggested that S1P 1 may interfere with sustained TGF-β signaling. S1P 1 inhibits the generation and maintenance of iT reg cells We then determined whether S1P 1 is needed to suppress iT reg differentiation. Given the fact that the progeny of mice with loxP-flanked S1pr1 alleles (S1pr1 flox/flox mice) crossed with mice transgenic for Cre recombinase driven by the Cd4 promoter (Cd4-Cre) have few peripheral T cells 14 , we bred those mice onto the Foxp3 gfp background and purified Foxp3 − CD4 + single-positive thymocytes. When transferred into Rag1 −/− mice, a subset of the donor cells became Foxp3 + . Deficiency in S1P 1 resulted in an augmented Foxp3 + population ( Fig. 2a) , which indicated the generation of more iT reg cells in vivo. To more directly address the requirement for S1P 1 in the development of iT reg cells from peripheral T cells, we crossed S1pr1 flox/flox mice with mice in which a gene encoding a fusion protein of Cre and the estrogen receptor is introduced into the ROSA26 locus (Rosa26-Cre-ER T2 mice; progeny called 'S1pr1 CreER mice' here). After treatment with 4-hydroxytamoxifen (4-OHT), the loxP-flanked S1pr1 gene was deleted in naive T cells ( Supplementary Fig. 3a ). When these cells were differentiated toward iT reg cells by exogenous TGF-β, they showed a higher frequency of the Foxp3 + population (Fig. 2b ) associated with greater abundance of Foxp3 mRNA ( Supplementary  Fig. 3b ) and normal cell survival (data not shown). Moreover, the CD103 + DC-induced Foxp3 + population was also enhanced in the absence of S1P 1 (Fig. 2c) . Therefore, S1P 1 deficiency directly potentiates iT reg differentiation.
Continued Foxp3 expression is necessary for T reg cell function. Foxp3 expression in iT reg cells is less stable than that in nT reg cells, and it depends on continuous TGF-β signaling in iT reg cells 16 . To assess the involvement of S1P 1 in the maintenance of Foxp3 expression, we generated and sorted Foxp3 + (GFP + ) iT reg cells from S1pr1 CreER mice and then treated the cells with 4-OHT to induce S1pr1 deletion in mature iT reg cells. After TGF-β withdrawal, control iT reg cells that retained S1P 1 expression readily lost Foxp3 expression, whereas iT reg cells deficient in S1P 1 encompassed a much larger Foxp3 + population with higher expression of Foxp3 and the cytokine receptor CD25 (Fig. 2d) . Conversely, Foxp3 + iT reg cells generated from S1P 1 -Tg mice were unable to sustain Foxp3 expression in the absence of TGF-β ( Supplementary Fig. 4 ). Therefore, S1P 1 negatively regulates the maintenance of Foxp3 expression in iT reg cells.
S1P 1 drives T H 1 differentiation
The inhibitory effects of S1P 1 on the induction and maintenance of iT reg cells prompted us to investigate whether S1P 1 diverges naive T cells into alternative lineages. For this we used three in vivo systems. First, in the oral antigen model of OT-II Rag1 −/− mice, only a small fraction of IFN-γ + cells was induced in OT-II Rag1 −/− mice, as would be expected for T cell responses under the tolerizing conditions. In contrast, S1P 1 -Tg OT-II Rag1 −/− mice contained a much larger population (five-to tenfold more abundant) of IFN-γ + CD4 + T cells in the various lymphoid organs examined ( Fig. 3a) . Accordingly, quantitative RT-PCR identified higher expression of IFN-γ and the T H 1 transcription factor T-bet in S1P 1 -Tg cells after oral antigen exposure (Fig. 3b) . The abundance of IL-4 and IL-17 protein and RNA was low and similar for the two types of mice ( Fig. 3a and data not shown), which indicated selective differentiation of S1P 1 -Tg cells into the T H 1 lineage.
Second, we adoptively transferred T cells from OT-II or S1P 1 -Tg OT-II mice (Thy-1.1 + ) into naive recipient mice and immunized the recipients intravenously with OVA. Five days later we detected a much larger IFN-γ + population among S1P 1 -Tg donor-derived cells than among wild-type donor cells ( Fig. 3c) . Also, secretion of IFN-γ, but not of IL-4 or IL-17, was enhanced in the group given transfer of S1P 1 -Tg cells after ex vivo peptide stimulation (data not shown).
Third, we determined the proportion of T cells able to produce IFN-γ in S1P 1 -Tg mice by intracellular cytokine staining. A higher percentage of CD4 + and CD8 + T cells in the MLNs of S1P 1 -Tg mice than those from wild-type mice produced IFN-γ ( Fig. 3d) . Quantitative RT-PCR showed that S1P 1 -Tg CD4 + and CD8 + T cells had seven-to eightfold more IFN-γ than did their wild-type counterparts ( Fig. 3d) . Thus, S1P 1 promotes IFN-γ production in vivo. 
A r t i c l e s
To establish whether S1P 1 regulates intrinsic T cell differentiation, we sorted naive T cells from wild-type and S1P 1 -Tg mice and cultured them under nonpolarizing (T H 0) conditions. A larger proportion of S1P 1 -Tg cells than wild-type cells spontaneously differentiated into IFN-γ + cells, associated with higher T-bet expression ( Supplementary Fig. 5a and data not shown). We also observed higher IFN-γ expression in S1P 1 -Tg OT-II cells ( Supplementary  Fig. 5a ) and in wild-type cells transduced with S1P 1 -expressing retrovirus than in those transduced with control retrovirus (data not shown). Conversely, deletion of S1P 1 resulted in lower IFN-γ expression ( Supplementary Fig. 5b ). Therefore, S1P 1 promotes IFN-γ expression and T H 1 differentiation.
S1P 1 directs reciprocal T H 1 and iT reg differentiation
We next determined the mechanisms for the altered iT reg and T H 1 differentiation in S1P 1 -Tg and S1P 1 -deficient cells. TGF-β is a pleiotropic cytokine with pronounced effects on the cell-fate determination of many T cell lineages 17 , but whether TGF-β directly coordinates the development of T H 1 cells and iT reg cells from naive precursor cells is not well understood. We therefore differentiated wild-type naive cells under T H 0 and T H 1 conditions in the presence of TGF-β and measured the expression of Foxp3 and IFN-γ simultaneously. As expected, a subset of cells expressed IFN-γ, but few expressed Foxp3, under nonpolarizing conditions. The addition of TGF-β induced Foxp3 expression and terminated IFN-γ expression. Under T H 1 conditions, most T cells became IFN-γ + , yet the addition of TGF-β resulted in a smaller IFN-γ + population and simultaneously induced a Foxp3 + population, which resulted in the coexistence of T H 1 cells and iT reg cells (Fig. 4a) . The ability of TGF-β to promote Foxp3 expression over IFN-γ expression was lost in S1P 1 -Tg cells (Fig. 4b) . In particular, when we added TGF-β to differentiating T H 1 cells to foster the development of both T H 1 cells and iT reg cells, the ratio of IFN-γ + cells to Foxp3 + cells was reversed for S1P 1 -Tg cells (Fig. 4c) . We also observed this reciprocal change for antigen-specific S1P 1 -Tg OT-II T cells ( Fig. 4c) . Conversely, deletion of S1P 1 resulted in the population expansion of iT reg cells at the expense of T H 1 cells ( Fig. 4d) . Therefore, S1P 1 mediates reciprocal T H 1 and iT reg differentiation in vitro.
As an independent system of T cell differentiation, we primed T cells with tolerogenic CD103 + DCs without any exogenous cytokines 6, 7 . Under these conditions, distinct populations of Foxp3 + and IFN-γ + cells were generated from wild-type cells. T cells with more S1P 1 signaling produced IFN-γ instead of Foxp3 ( Fig. 4e) , whereas those deficient in S1P 1 'preferentially' developed into Foxp3 + T reg cells instead of IFN-γ + T H 1 cells ( Fig. 4f) . These results further indicate an intrinsic role for S1P 1 in directing T H 1 and iT reg lineage commitment.
Published studies have shown that T H 1 cells and IFN-γ are pathogenic in colitis 18 , whereas iT reg cells act in synergy with nT reg cells to establish mucosal tolerance 19 . To determine the in vivo relevance of S1P 1 -mediated T cell differentiation, we transferred naive T cells from wild-type or S1P 1 -Tg (CD45.2 + ) mice in conjunction with wildtype congenic (CD45.1 + ) T reg cells into Rag1 −/− mice. In this system, iT reg cells developed in situ from naive donors, together with nT reg donor cells, are needed to control colitis 19 ; we used wild-type nT reg cells here to circumvent the confounding effects in S1P 1 -Tg nT reg cells 14 . Although there was minimal weight loss and inflammation in the group given cotransfer of wild-type cells, transfer of S1P 1 -Tg naive cells and wild-type T reg cells resulted in substantial weight loss associated with severe colitis and leukocyte infiltration ( Fig. 4g,h) . To delineate the underlying mechanisms, we measured the expression of Foxp3 and IFN-γ in cells derived from naive (CD45.2 + ) cell donors. We observed fewer Foxp3 + iT reg cells from S1P 1 -Tg donors than their wild-type counterparts and significanty more IFN-γ-expressing T cells ( Fig. 4i) . Therefore, S1P 1 
controls the reciprocal relationship between iT reg cells and T H 1 cells in vivo.

Discrete mechanisms for iT reg and T H 1 differentiation
We next determined whether control of T H 1 and iT reg differentiation by S1P 1 is interdependent. IFN-γ can inhibit the generation of iT reg cells 20 , although conflicting conclusions also exist 21 . We tested whether inhibition of iT reg differentiation by S1P 1 is a secondary consequence of more IFN-γ production. Retroviral transduction of S1P 1 into either Ifng −/− or wildtype cells resulted in less induction of Foxp3 + cells under iT reg conditions (Fig. 5a) . Also, the S1P 1 transgene resulted in impaired generation of iT reg cells in both the Ifng +/+ and Ifng −/− backgrounds (Fig. 5b) . Thus, S1P 1 regulates iT reg differentiation independently of its role in facilitating IFN-γ expression.
Conversely, we tested whether the lower Foxp3 expression in S1P 1 -Tg cells was responsible for their enhanced IFN-γ expression. For this we transduced Foxp3 into wild-type and S1P 1 -Tg cells and found that forced Foxp3 expression did not lower the expression of IFN-γ in S1P 1 -Tg cells (Fig. 5c) . To further assess the function of Foxp3 in S1P 1 -mediated T H 1 differentiation, we assessed whether Foxp3 deficiency affected the ability of S1P 1 to drive T H 1 differentiation. To prevent the lymphoproliferative autoimmune phenotype due to Foxp3 deficiency, we constructed mixed-bone marrow chimeras by cotransferring bone marrow cells from Foxp3-deficient scurfy (CD45.1 + CD45.2 + ) mice and wild-type (CD45.2 + ) mice into Rag1 −/− recipients; the presence of functional T reg cells derived from the wild-type donors prevented autoimmune activation of scurfy T cells 14 . We purified naive T cells from these two donor populations and transduced them with S1P 1 -expressing retrovirus. S1P 1 expression was equally effective in promoting IFN-γ expression in wild-type and Foxp3-deficient cells (Fig. 5d) . As an independent approach, we bred OT-II and S1P 1 -Tg OT-II mice with scurfy mice, in which the TCR transgene ameliorated the confounding effects of autoimmune inflammation 22 . We stimulated naive T cells from the progeny with OVA peptide and found more T H 1 differentiation in those expressing the S1P 1 transgene (Fig. 5e) . Therefore, either ectopic expression of or deficiency in Foxp3 did not prevent S1P 1 from driving T H 1 differentiation, which suggested that S1P 1 mediates T H 1 differentiation independently of its effects on the inhibition of Foxp3 expression.
Aged S1P 1 -Tg mice developed high titers of autoantibodies, concomitant with spontaneous T cell activation 14 . As IFN-γ production is associated with the pathogenesis of systemic autoimmune disease, we assessed whether more IFN-γ in S1P 1 -Tg cells contributed to the breakdown of immune tolerance. S1P 1 -Tg Ifng −/− mice had titers of antibody to double-stranded DNA 35% as high as those of S1P 1 -Tg Ifng +/+ mice (data not shown). In contrast, we observed higher expression of CD44 on S1P 1 -Tg cells, indicative of their spontaneous activation in vivo 14 , regardless of the Ifng +/+ or Ifng −/− background (data not shown), consistent with the published observation that spontaneous T cell activation is due mainly to defective T reg cells in S1P 1 -Tg mice 14 . Therefore, S1P 1 regulates immune homeostasis through both T reg cell-dependent and T reg cell-independent mechanisms. 1 0 5 2 VOLUME 11 NUMBER 11 NOVEMBER 2010 nature immunology A r t i c l e s S1P 1 antagonizes TGF-b-Smad3 signaling We noticed that the exacerbated colitis after the transfer of S1P 1 -Tg cells was a phenocopy of the abnormalities of T cells with transgenic expression of a dominant negative TGF-β receptor (CD4-dnTGFβRII) in a similar model 23, 24 . Moreover, mice with impaired TGF-β receptor signaling in T cells spontaneously differentiate into T H 1 cells in vivo 25, 26 . We hypothesized that S1P 1 mediates reciprocal T H 1 and iT reg differentiation by antagonizing TGF-β receptor signaling. To test our hypothesis, we first compared the response of S1P 1 -Tg cells with that of CD4-dnTGFβRII cells. In response to CD103 + DCs, both S1P 1 -Tg and CD4-dnTGFβRII T cells were skewed into IFN-γ + T H 1 cells rather than Foxp3 + T reg cells (Fig. 6a) . Similarly, in response to exogenous TGF-β, CD4-dnTGFβRII and S1P 1 -Tg cells had similar defects in upregulating Foxp3; instead, these cells expressed IFN-γ ( Supplementary Fig. 6) . Therefore, the abnormalities of CD4-dnTGFβRII mice are a phenocopy of the abnormalities of S1P 1 -Tg mice, which suggests that S1P 1 probably affects TGF-β receptor signaling. We next investigated the molecular mechanisms by which S1P 1 and the TGF-β receptor interact. Smad3 is an important transcription Vehicle WT WT S1pr1 CreER S1pr1 CreER Foxp3
SlS3 Cells factor that mediates the effects of TGF-β in the generation of iT reg cells 27 . TGF-β stimulation resulted in prolonged activation of Smad3 in wild-type T cells (Supplementary Fig. 7a ). Immediately after TGFβ stimulation, Smad3 phosphorylation was similar in wild-type and S1P 1 -Tg cells (data not shown). However, S1P 1 -Tg cells were unable to maintain Smad3 phosphorylation after 16 h of TGF-β treatment, especially at 24-48 h of stimulation (Supplementary Fig. 7a) . Accordingly, nuclear translocation of total and phosphorylated Smad3 was much lower in S1P 1 -Tg cells after 2 d of stimulation (Fig. 6b) . To understand the importance of sustained Smad3 activation, we transduced a dominant negative Smad3 molecule into wild-type cells 24 h after initiating iT reg differentiation; this was effective in inhibiting Foxp3 induction (Supplementary Fig. 7b) . Moreover, we observed more phosphorylation of Smad3 in S1P 1 -deficient cells at and after 24 h of stimulation (Supplementary Fig. 8 ). To directly determine whether Smad3 mediates S1P 1 function, we introduced constitutively active Smad3 into S1P 1 -Tg cells, which restored Foxp3 expression in S1P 1 -Tg cells by up to 60% (Fig. 6c) . Conversely, treatment of S1P 1 -deficient T cells with a Smad3 inhibitor resulted in less iT reg differentiation (Fig. 6d) . Therefore, S1P 1 antagonizes TGF-β-dependent effects on T cell differentiation mainly by attenuating sustained Smad3 signaling.
The S1P 1 -mTOR axis is targeted by immunosuppressants We further explored the signaling pathway used by S1P 1 to antagonize TGF-β-Smad3 signaling. The Akt-mTOR pathway has been shown to restrain the generation of iT reg cells [28] [29] [30] [31] . However, S1P 1 activates Akt in nT reg cells but not in naive T cells immediately after TCR stimulation 14 . Given the effects of S1P 1 on sustained but not early Smad3 activation, we examined mTOR activity at later time points by assessing phosphorylation of the ribosomal protein S6, a well-established target of mTOR. S1P 1 -Tg cells had more phosphorylation of S6 after 16 h of TCR stimulation and had even more prominent increase at later time points (Fig. 7a) , which indicated an important role for S1P 1 in sustaining mTOR activation.
The S1P 1 -mediated reciprocal differentiation of iT reg and T H 1 cells identified above led us to examine possible therapeutic implications. Both rapamycin, an inhibitor of mTOR, and the immunosuppressant FTY720 have been shown to modulate iT reg cells [28] [29] [30] 32 . To address whether FTY720 and rapamycin share an immunosuppressive mechanism, we first examined mTOR activation in S1P 1 -Tg cells treated with FTY720 or rapamycin. FTY720 and rapamycin each resulted in less phosphorylation of S6 (Supplementary Fig. 9 ). Moreover, each treatment restored the activity of phosphorylated Smad3 in S1P 1 -Tg cells to that in wild-type cells (Fig. 7b) . These results identified an S1P 1 -mTOR axis that acts to interfere with Smad3 signaling and is targeted by immunosuppressive drugs.
To further investigate the effects of the immunosuppressants on immune responses, we administered oral OVA antigen to OT-II Rag1 −/− mice and treated them daily with FTY720 or rapamycin. Such treatment resulted in more iT reg cells and fewer IFN-γ + T H 1 cells (Supplementary Fig. 10) . Treatment of S1P 1 -Tg OT-II Rag1 −/− mice with FTY720 or rapamycin reversed the altered differentiation of iT reg and T H 1 cells, resembling the differentiation in untreated A r t i c l e s wild-type control mice (Fig. 7c,d) . Thus, FTY720 and rapamycin modulate reciprocal T H 1 and iT reg differentiation in vivo. To ascertain whether this reflected intrinsic effects, we treated T cells with these drugs in vitro. Treatment of S1P 1 -Tg cells with FTY720 or rapamycin resulted in more iT reg differentiation and less T H 1 differentiation (Supplementary Fig. 11 ). Thus, FTY720 and rapamycin directly modulate reciprocal differentiation of iT reg and T H 1 cells by targeting the S1P 1 -mTOR axis. We next sought to determine whether FTY720 and rapamycin also target thymic nT reg cells. We treated wild-type and S1P 1 -Tg mice with FTY720 or rapamycin for 5 d and assessed the frequency of Foxp3 + CD4 + single-positive thymocytes. As reported before, S1P 1 -Tg mice had fewer thymic nT reg cells 14 . After treatment with FTY720 or rapamycin, nT reg cells in these mice were similar to those in wild-type mice (Fig. 7e) . Accordingly, the diminished in vitro differentiation of S1P 1 -Tg nT reg precursor (CD25 + Foxp3 − ) cells into mature Foxp3 + cells was restored by FTY720 and rapamycin ( Supplementary Fig. 12 ). Therefore, FTY720 and rapamycin affect the thymic development of nT reg cells by targeting the S1P 1 -mTOR axis.
To further explore whether Smad3 mediates S1P 1 signaling in thymic nT reg cell differentiation, we treated nT reg precursor cells from wild-type and S1pr1 flox/flox Cd4-Cre mice with the Smad3 inhibitor SIS3. Blocking Smad3 activity ablated the greater nT reg differentiation observed for precursor cells lacking S1P 1 (Fig. 7f) . Although TGF-β is required for the survival of T reg cells in the thymus 33 , SIS3 treatment resulted in less Foxp3 induction even in Bcl-2-transgenic mice (data not shown), which indicated that the effect of Smad3 in nT reg differentiation is independent of cell survival. Thus, the drugsensitive S1P 1 -mTOR axis interferes with Smad3 signaling to control development of both nT reg and iT reg subsets.
Sphingosine kinases control T cell differentiation
Given an essential role of S1P 1 in T reg cell differentiation, we explored mechanisms of S1P 1 activation. Supplementing naive T cells with exogenous S1P did not alter their differentiation into iT reg cells (Fig. 8a) . We thus tested whether endogenously produced S1P is involved. S1P is synthesized by one of the two sphingosine kinases on the substrate sphingosine 34 . In differentiating T cells, the sphingosine kinase SphK1 was considerably upregulated by treatment with TGF-β ( Fig. 8b) , which suggested that intrinsic sphingosine kinase activity was probably involved in the regulation of iT reg differentiation. To test that hypothesis, we treated naive T cells with DMS or SKI, two widely used inhibitors of sphingosine kinase activity. Blocking sphingosine kinase activity resulted in considerable upregulation of Foxp3 induction (Fig. 8c) . Moreover, treatment of S1P 1 -Tg cells with DMS or SKI restored their ability to differentiate into iT reg cells (Fig. 8d) . Similarly, blocking sphingosine kinase activity considerably rectified the defects of S1P 1 -Tg cells in reciprocal T H 1 and T reg differentiation (Supplementary Fig. 13a) . Thus, T cell differentiation mediated by S1P 1 is dependent on intrinsic sphingosine kinases, whose expression is upregulated by TGF-β as a feedback mechanism to limit TGF-β responses (Supplementary Fig. 13b) .
DISCUSSION
Our results have demonstrated that the differentiation of T H 1 cells and T reg cells is reciprocally regulated. We found that S1P 1 was a switch factor that drove the development of T H 1 cells at the expense of T reg cell generation. S1P 1 function was dependent on endogenous sphingosine kinase activity, and it signaled through mTOR and intersected with TGF-β signaling mainly by attenuating sustained Smad3 activity. Although TGF-β and mTOR have pleiotropic functions in regulating many CD4 + T cell lineages 17, 30 , the interaction between S1P 1 -mTOR and TGF-β-Smad3 signaling with dynamic kinetics selectively controlled the reciprocal differentiation of T H 1 cells and T reg cells. We propose that this previously unknown lineage-commitment process controls the balance between immunity and tolerance and contributes to mechanisms of action for immunosuppressive therapy.
The dichotomy of T H 1 and T reg cell-fate determination is reminiscent of the reciprocal differentiation of iT reg cells and T H 17 cells 1, 4 . Moreover, the effect on T cell differentiation by S1P 1 , a G protein-coupled receptor for the endogenous bioactive lipid S1P, is analogous to the control of reciprocal iT reg and T H 17 differentiation mediated by non-cytokine receptors such as the retinoid acid receptor and aryl hydrocarbon receptor, which recognize certain endogenous metabolites and environmental toxins [5] [6] [7] [8] [9] . These results collectively establish a new paradigm of T cell lineage specification controlled by non-cytokine immune modulators. Unlike the inhibition of T H 17 differentiation by Foxp3 (refs. 22, 35, 36) , ectopic expression or complete ablation of Foxp3 did not prevent S1P 1 differentiation. Moreover, S1P 1 blocked the generation of iT reg cells independently of its ability to drive T H 1 differentiation. Thus, S1P 1 regulates T H 1 and iT reg differentiation through discrete mechanisms, in further support of the reciprocal nature of these two lineages.
High S1P 1 expression is associated with various autoimmune diseases 37 . A direct role for S1P 1 in immune homeostasis is highlighted by the development of autoimmunity in aged S1P 1 -Tg mice 14 , attributed to defects in both T reg cells and naive T cells. Also, transfer of either regulatory or naive S1P 1 -Tg cells into Rag1 −/− mice exacerbates the development of colitis 14 . These observations are reminiscent of TGF-β-dependent immune homeostasis via T reg cell-dependent and T reg cell-independent mechanisms 25 . Notably, premature egress of CD4 + CD8 + thymocytes from the thymus into peripheral lymphoid organs and tissues has been observed in another strain of S1P 1transgenic mice in which an artificial promoter is used to drive transgene expression in both T cells and B cells 38 . We did not observe such alterations in several lines of founder mice expressing the S1P 1 transgene via the T cell-selective CD2 promoter-enhancer 13 (data not shown). The simplest interpretation for this discordance is the use of different promoters for transgene expression. Notably, fewer thymic nT reg cells were apparent in both types of transgenic mice 14, 38 , which emphasizes the key function of S1P 1 in T reg differentiation. S1P 1 attenuates TGF-β-Smad3 function via signaling through mTOR. Although Smad3 is activated within minutes of TGF-β stimulation, sustained Smad3 activity, which is antagonized by the S1P 1 -mTOR axis, is essential for iT reg differentiation. This is in agreement with the observed 48-hour delay in Foxp3 expression after TGF-β treatment 16 . The effect of S1P 1 on mTOR signaling in naive T cells is distinct from its function in nT reg cells, in which it facilitates immediate mTOR activation 14 , which suggests cell context-specific regulation of mTOR signaling. Despite that, the S1P 1 -mTOR axis negatively regulates the differentiation of both thymic nT reg cells and extrathymic iT reg cells by antagonizing TGF-β-Smad3 signaling. Although the roles of TGF-β in nT reg development remain controversial 33, 39 , a requirement for Smad3 signaling in this process has bveen established by the finding of fewer thymic nT reg cells in Smad3 −/− mice 40 . This probably reflects the engagement of multiple and potentially opposing signaling pathways by TGF-β, as well as the pleiotropic effects of TGF-β on T cell development and homeostasis 17 . Thus, whereas diverse mechanisms promote the generation of nT reg and iT reg cells 3 , a common pathway involving S1P 1 -mTOR and antagonistic interactions with TGF-β-Smad3 signaling negatively controls the differentiation of both T reg subsets.
Signaling by mTOR is necessary for the differentiation of many effector T cells, including T H 1, T H 2 and T H 17 cells, while at the same time it inhibits the generation of iT reg cells 30 . Here we found that the S1P 1 -mTOR axis selectively controlled T H 1 and T reg differentiation, which suggests that other receptors may mediate mTOR activation for T H 2 and T H 17 differentiation. Although published reports have shown that a human S1P 1 transgene is able to promote the generation of T H 2 and T H 17 cells in vitro 41, 42 , we found no evidence for the involvement of S1P 1 in these processes after antigen stimulation in vivo. Determining whether S1P 1 regulates these processes under more defined conditions will require further testing. Additional molecules involved in Akt-mTOR signaling, including Rictor (mTORC2), Cbl-b, Foxo1 and Foxo3, have been shown to modulate T cell responses 30, 43, 44 . Given the potent effects of S1P 1 on the induction and maintenance of T reg cells and the generation of T H 1 cells, S1P 1 may engage diverse pathways associated with Akt-mTOR. Furthermore, direct interactions between Smad3 and the Akt, mTOR and Foxo transcription factor pathways have been observed outside the immune system 45, 46 , which suggests that Smad3 may integrate these pathways to direct T cell differentiation.
High concentrations of S1P are maintained in the blood and lymph by the actions of sphingosine kinases, but low concentrations are induced in lymphoid organs by S1P lyase. Separate sources seem to provide S1P to plasma and lymph 47 , and a study has indicated that neural crest-derived pericytes produce S1P to induce thymocyte egress 38 . Combining pharmacological and genetic approaches, here we found that S1P 1 -mediated regulation of T cell differentiation required endogenous sphingosine kinase activity. Although exogenously added S1P had no apparent effects on T reg cell generation, we cannot completely exclude the possibility of a contribution by the exogenous source of S1P in this process, because S1P distribution might not have been recapitulated in the isolated cell cultures. Nonetheless, our results have demonstrated a key role for endogenously produced S1P in T cell differentiation in an autocrine and/or paracrine way. Moreover, SphK1 expression was upregulated substantially by TGF-β stimulation, which probably serves as a feedback mechanism to restrain prolonged effects of TGF-β on Foxp3 expression. In growth factoractivated cells, S1P has been found to be produced and secreted from the cell to activate S1P receptors in its vicinity in a model known as 'inside-out' signaling of S1P 34 . To our knowledge, our work represents the first identification of similar modes of action for S1P in T cell responses.
We further demonstrated that S1P 1 links fundamental processes of T cell lineage commitment to immunosuppressive therapy. FTY720 and rapamycin are thought to affect distinct molecular and cellular pathways in T cells by acting on S1P 1 to induce lymph node sequestration and on mTOR to block cell cycle entry, respectively 10, 31 . Here we found that these two potent immunosuppressants targeted the same S1P 1 -mTOR axis to modulate the balance between proinflammatory T H 1 cells and anti-inflammatory T reg cells in vivo. These effects are probably T cell intrinsic, as we were able to recapitulate their functions with in vitro culture systems. Therefore, the regulation of T cell lineage 'choices' by the S1P 1 -mTOR axis can be further explored to develop new therapeutics for autoimmunity and transplant rejection.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
